REPL Replimune Group, Inc. logo

REPL Replimune Group, Inc.

Healthcare
$4.58+0.00%OpenMarket Cap: $377.8M

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

184

13F Shares

79,746,702

Ownership %

86.5%

New Positions

32

Increased Positions

93

Closed Positions

36

Reduced Positions

56

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
CNCRLoncar Cancer Immunotherapy ETF47,1933.54%
PTHInvesco Dorsey Wright Healthcare Momentum ETF138,0440.89%
BBCVirtus Biotech Clinical Trials ETF26,7860.59%
MEDXHorizon Kinetics Medical ETF13,1880.54%
CANCTema Oncology ETF106,1890.48%
DWASInvesco Dorsey Wright SmallCap Momentum ETF141,0840.30%
XBI2,198,3860.23%
LABUDirexion Daily S&P Biotech Bull 3X ETF111,4700.17%
TMSLT. Rowe Price Small-Mid Cap ETF243,9820.12%
IJE181,4870.11%
IWCiShares Micro-Cap ETF181,4870.11%
FESMFidelity Enhanced Small Cap ETF494,4130.09%
VFMO81,8330.07%
IBBiShares Biotechnology ETF570,9300.05%
PRFZInvesco RAFI US 1500 Small-Mid ETF151,4630.04%
NAJ606,2160.04%
IWNiShares Russell 2000 Value ETF606,2160.04%
VTWV51,3630.04%
RSSLGlobal X - Russell 2000 ETF31,5800.02%
IWMiShares Russell 2000 ETF1,732,2930.02%